AMD has been preparing to launch its MI100 accelerator and fight NVIDIA's A100 Ampere GPU in machine learning and AI horizon, and generally compute-intensive workloads. According to some news sources over at AdoredTV, the GPU alleged specifications were listed, along with some slides about the GPU which should be presented at the launch. So to start, this is what we have on the new Radeon MI100 "Arcturus" GPU based on CDNA architecture. The alleged specifications mention that the GPU will feature 120 Compute Units (CUs), meaning that if the GPU keeps the 64-core per CU configuration, we are looking at 7680 cores powered by CDNA architecture.

The leaked slide mentions that the GPU can put out as much as 42 TeraFLOPs of FP32, single-precision compute. This makes it more than twice as fast compared to NVIDIA's A100 GPU at FP32 workloads. To achieve that, the card would need to have all of its 7680 cores running at 2.75 GHz, which would be a bit high number. On the same slide, the GPU is claimed to have 9.5 TeraFLOPs of FP64 dual-precision performance, while the FP16 power is going to be around 150 TeraFLOPs. For comparison, the A100 GPU from NVIDIA features 9.7 TeraFLOPS of FP64, 19.5 TeraFLOPS of FP32, and 312 (or 634 with sparsity enabled) TeraFLOPs of FP16 compute. AMD GPU is allegedly only more powerful for FP32 workloads, where it outperforms the NVIDIA card by 2.4 times. And if that is really the case, AMD has found its niche in the HPC sector, and it plans to dominate there. According to AdoredTV sources, the GPU could be coming in December of this year.

AMD late Tuesday released its Q2-2020 financial results, which saw the company rake in revenue of $1.93 billion for the quarter, and clock a 26 percent YoY revenue growth. In both its corporate presentation targeted at the financial analysts, and its post-results conference call, AMD revealed a handful interesting bits looking into the near future. Much of the focus of AMD's presentation was in reassuring investors that [unlike Intel] it is promising a stable and predictable roadmap, that nothing has changed on its roadmap, and that it intends to execute everything on time. "Over the past couple of quarters what we've seen is that they see our performance/capability. You can count on us for a consistent roadmap. Milan point important for us, will ensure it ships later this year. Already started engaging people on Zen4/5nm. We feel customers are very open. We feel well positioned," said president and CEO Dr Lisa Su.

For starters, there was yet another confirmation from the CEO that the company will launch the "Zen 3" CPU microarchitecture across both the consumer and data-center segments before year-end, which means both Ryzen and EPYC "Milan" products based on "Zen 3." Also confirmed was the introduction of the RDNA2 graphics architecture across consumer graphics segments, and the debut of the CDNA scalar compute architecture. The company started shipping semi-custom SoCs to both Microsoft and Sony, so they could manufacture their next-generation Xbox Series X and PlayStation 5 game consoles in volumes for the Holiday shopping season. Semi-custom shipments could contribute big to the company's Q3-2020 earnings. CDNA won't play a big role in 2020 for AMD, but there will be more opportunities for the datacenter GPU lineup in 2021, according to the company. CDNA2 debuts next year.

Mark Papermaster, chief technology officer and executive vice president of Technology and Engineering at AMD, today confirmed that CDNA is on-track for release in 2H2020 for HPC computing. The confirmation was (adequately) given during Dell's EMC High-Performance Computing Online event. This confirms that AMD is looking at a busy 2nd half of the year, with both Zen 3, RDNA 2 and CDNA product lines being pushed to market.

CDNA is AMD's next push into the highly-lucrative HPC market, and will see the company differentiating their GPU architectures through market-based product differentiation. CDNA will see raster graphics hardware, display and multimedia engines, and other associated components being removed from the chip design in a bid to recoup die area for both increased processing units as well as fixed-function tensor compute hardware. CNDA-based Radeon Instinct MI100 will be fabricated under TSMC's 7 nm node, and will be the first AMD architecture featuring shared memory pools between CPUs and GPUs via the 2nd gen Infinity Fabric, which should bring about both throughput and power consumption improvements to the platform.

Several future AMD processor codenames across various computing segments surfaced courtesy of an Expreview leak that's largely aligned with information from Komachi Ensaka. It does not account for "Matisse Refresh" that's allegedly coming out in June-July as three gaming-focused Ryzen socket AM4 desktop processors; but roadmap from 2H-2020 going up to 2022 sees many codenames surface. To begin with, the second half of 2020 promises to be as action packed as last year's 7/7 mega launch. Over in the graphics business, the company is expected to debut its DirectX 12 Ultimate-compliant RDNA2 client graphics, and its first CDNA architecture-based compute accelerators. Much of the processor launch cycle is based around the new "Zen 3" microarchitecture.

The server platform debuting in the second half of 2020 is codenamed "Genesis SP3." This will be the final processor architecture for the SP3-class enterprise sockets, as it has DDR4 and PCI-Express gen 4.0 I/O. The EPYC server processor is codenamed "Milan," and combines "Zen 3" chiplets along with an sIOD. EPYC Embedded (FP6 package) processors are codenamed "Grey Hawk."

AMD is preparing to launch its next-generation of Radeon Instinct GPUs based on the new CDNA architecture designed for enterprise deployments. Thanks to the popular hardware leaker _rogame (@_rogame) we have some information about the configuration of the upcoming Radeon Instinct MI100 "Arcturus" server GPU. Previously, we obtained the BIOS of the Arcturus GPU that showed a configuration of 128 Compute Units (CUs), which resulted in 8,192 of CDNA cores. That configuration had a specific setup of 1334 MHz GPU clock, SoC frequency of 1091 MHz, and memory speed of 1000 MHz. However, there was another GPU test board spotted which featured a bit different specification.

The reported configuration is an Arcturus GPU with 120 CUs, resulting in a CDNA core count of 7,680 cores. These cores are running at frequencies of 878 MHz for the core clock, 750 MHz SoC clock, and a surprising 1200 MHz memory clock. While the SoC and core clocks are lower than the previous report, along with the CU count, the memory clock is up by 200 MHz. It is important to note that this is just a test board/variation of the MI100, and actual frequencies should be different.

AMD at its 2020 Financial Analyst Day event unveiled its upcoming CDNA GPU-based compute accelerator architecture. CDNA will complement the company's graphics-oriented RDNA architecture. While RDNA powers the company's Radeon Pro and Radeon RX client- and enterprise graphics products, CDNA will power compute accelerators such as Radeon Instinct, etc. AMD is having to fork its graphics IP to RDNA and CDNA due to what it described as market-based product differentiation.

Data centers and HPCs using Radeon Instinct accelerators have no use for the GPU's actual graphics rendering capabilities. And so, at a silicon level, AMD is removing the raster graphics hardware, the display and multimedia engines, and other associated components that otherwise take up significant amounts of die area. In their place, AMD is adding fixed-function tensor compute hardware, similar to the tensor cores on certain NVIDIA GPUs.

AMD Financial Analyst Day presents an opportunity for AMD to talk straight with the finance industry about the company's current financial health, and a taste of what's to come. Guidance and product teasers made during this time are usually very accurate due to the nature of the audience. In this live blog, we will post information from the Financial Analyst Day 2020 as it unfolds.20:59 UTC: The event has started as of 1 PM PST. CEO Dr Lisa Su takes stage.